Advertisement

Topics

Smell test challenge suggests clinical benefit for some before development of Alzheimer's

19:00 EST 9 Nov 2017 | AAAS

(Columbia University Medical Center) In a new study, researchers have determined that a declining sense of smell may be able to identify patients with mild cognitive impairment that could respond to certain drugs used to treat Alzheimer's disease.

Original Article: Smell test challenge suggests clinical benefit for some before development of Alzheimer's

NEXT ARTICLE

More From BioPortfolio on "Smell test challenge suggests clinical benefit for some before development of Alzheimer's"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...